Dianthus Therapeutics, Inc. /DE/ ($DNTH)
CARR EDWARD โ CHIEF ACCOUNTING OFFICER
Shares
17,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 9, 2026
EPS:-1.43 (est: -1.01)+42.2%
Revenue:$284.00K (est: $242.22K)+17.2%
Mar 10, 2026
EPS:Est: -0.97
Transaction Details
| Insider | CARR EDWARD |
|---|---|
| Title | CHIEF ACCOUNTING OFFICER |
| Transaction Date | Mar 12, 2026 |
| Expiration Date | Feb 3, 2035 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 14, 2026 |
| Shares Purchased | 17,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 42,500 |
| Derivative | Derivative |
| Accession Number | 0001273351-26-000004 |
| Document | View SEC Filing |